Literature DB >> 25752304

Is gentamicin affecting the neuromuscular system of critically ill patients?

Luuk Wieske1, Reinier M van Hest, Esther Witteveen, Camiel Verhamme, Marcus J Schultz, Ivo N van Schaik, Janneke Horn.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 25752304     DOI： 10.1007/s00134-015-3731-3

Source DB:  PubMed          Journal:  Intensive Care Med        ISSN： 0342-4642            Impact factor:   17.440


× No keyword cloud information.
  5 in total

Review 1.  Critical illness polyneuropathy and myopathy: a major cause of muscle weakness and paralysis.

Authors:  Nicola Latronico; Charles F Bolton
Journal:  Lancet Neurol       Date:  2011-10       Impact factor: 44.182

Review 2.  Neurotoxic effects associated with antibiotic use: management considerations.

Authors:  Marie F Grill; Rama K Maganti
Journal:  Br J Clin Pharmacol       Date:  2011-09       Impact factor: 4.335

3.  Competitive and open channel block of recombinant nAChR channels by different antibiotics.

Authors:  Friedrich Schlesinger; Klaus Krampfl; Gertrud Haeseler; Reinhard Dengler; Johannes Bufler
Journal:  Neuromuscul Disord       Date:  2004-05       Impact factor: 4.296

4.  Early prediction of intensive care unit-acquired weakness using easily available parameters: a prospective observational study.

Authors:  Luuk Wieske; Esther Witteveen; Camiel Verhamme; Daniela S Dettling-Ihnenfeldt; Marike van der Schaaf; Marcus J Schultz; Ivo N van Schaik; Janneke Horn
Journal:  PLoS One       Date:  2014-10-27       Impact factor: 3.240

5.  Do bupivacaine, clindamycin, and gentamicin at their clinical concentrations enhance rocuronium-induced neuromuscular block?

Authors:  Soo-Il Lee; Ji Hyeon Lee; Sang Yoong Park; Jae-Won Park
Journal:  Korean J Anesthesiol       Date:  2013-04-22
  5 in total
  2 in total

1.  Intensive care unit-acquired weakness: A review from molecular mechanisms to its impact in COVID-2019.

Authors:  Andrea Gonzalez; Johanna Abrigo; Oscar Achiardi; Felipe Simon; Claudio Cabello-Verrugio
Journal:  Eur J Transl Myol       Date:  2022-08-26

Review 2.  ICU-acquired weakness.

Authors:  Ilse Vanhorebeek; Nicola Latronico; Greet Van den Berghe
Journal:  Intensive Care Med       Date:  2020-02-19       Impact factor: 17.440
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.